PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ADC Therapeutics SA (ADCT)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCH0499880968
CUSIP049988096
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$394.53M
EPS-$2.77
PE Ratio8.34
Revenue (TTM)$68.62M
Gross Profit (TTM)$35.10M
EBITDA (TTM)-$148.13M
Year Range$0.36 - $6.04
Target Price$10.00
Short %1.59%
Short Ratio1.89

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ADC Therapeutics SA

Popular comparisons: ADCT vs. GERN

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in ADC Therapeutics SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%December2024FebruaryMarchAprilMay
-87.42%
85.82%
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)

S&P 500

Returns By Period

ADC Therapeutics SA had a return of 124.70% year-to-date (YTD) and 40.23% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date124.70%11.56%
1 month-20.97%7.13%
6 months415.19%17.26%
1 year40.23%26.92%
5 years (annualized)N/A13.56%
10 years (annualized)N/A10.87%

Monthly Returns

The table below presents the monthly returns of ADCT, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202487.95%54.81%-7.04%-1.78%124.70%
202333.07%-29.55%-45.83%-0.51%21.13%-8.51%-31.16%-18.92%-25.25%-21.96%18.57%100.00%-56.77%
2022-21.34%5.10%-12.04%-19.88%-41.89%16.23%-6.79%-7.96%-29.33%-7.88%-17.57%4.92%-80.99%
2021-10.75%-6.93%-8.20%0.53%-11.78%12.47%-13.59%38.64%-6.89%6.74%-23.21%-9.25%-36.89%
202024.62%26.68%-0.66%-5.01%-25.31%-13.03%30.05%-14.21%7.96%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ADCT is 63, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of ADCT is 6363
ADCT (ADC Therapeutics SA)
The Sharpe Ratio Rank of ADCT is 5757Sharpe Ratio Rank
The Sortino Ratio Rank of ADCT is 7171Sortino Ratio Rank
The Omega Ratio Rank of ADCT is 6767Omega Ratio Rank
The Calmar Ratio Rank of ADCT is 6565Calmar Ratio Rank
The Martin Ratio Rank of ADCT is 5757Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for ADC Therapeutics SA (ADCT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ADCT
Sharpe ratio
The chart of Sharpe ratio for ADCT, currently valued at 0.37, compared to the broader market-2.00-1.000.001.002.003.004.000.37
Sortino ratio
The chart of Sortino ratio for ADCT, currently valued at 1.56, compared to the broader market-4.00-2.000.002.004.006.001.56
Omega ratio
The chart of Omega ratio for ADCT, currently valued at 1.19, compared to the broader market0.501.001.502.001.19
Calmar ratio
The chart of Calmar ratio for ADCT, currently valued at 0.47, compared to the broader market0.002.004.006.000.47
Martin ratio
The chart of Martin ratio for ADCT, currently valued at 1.06, compared to the broader market-10.000.0010.0020.0030.001.06
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.34, compared to the broader market-2.00-1.000.001.002.003.004.002.34
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.31, compared to the broader market-4.00-2.000.002.004.006.003.31
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.41, compared to the broader market0.501.001.502.001.41
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.90, compared to the broader market0.002.004.006.001.90
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.93, compared to the broader market-10.000.0010.0020.0030.008.93

Sharpe Ratio

The current ADC Therapeutics SA Sharpe ratio is 0.37. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of ADC Therapeutics SA with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
0.37
2.34
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)

Dividends

Dividend History


ADC Therapeutics SA doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-92.69%
0
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the ADC Therapeutics SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the ADC Therapeutics SA was 99.08%, occurring on Nov 9, 2023. The portfolio has not yet recovered.

The current ADC Therapeutics SA drawdown is 92.69%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.08%Jul 6, 2020845Nov 9, 2023
-7.91%May 29, 20206Jun 5, 20204Jun 11, 202010
-3.03%Jun 15, 20203Jun 17, 20202Jun 19, 20205
-1.2%Jun 24, 20202Jun 25, 20202Jun 29, 20204
-0.71%May 27, 20201May 27, 20201May 28, 20202

Volatility

Volatility Chart

The current ADC Therapeutics SA volatility is 24.51%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%December2024FebruaryMarchAprilMay
24.51%
3.10%
ADCT (ADC Therapeutics SA)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of ADC Therapeutics SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items